Haojing Rong

VP, Preclinical Development

Haojing is the Vice President of Preclinical Development at Kymera Therapeutics. Prior to joining Kymera in 2018, Haojing worked at Amgen, Merck, Amira Pharmaceuticals, Pfizer, and Shire. Haojing’s interest and expertise include ADME and Tox knowledge integration for both small molecule and biotherapeutics, prediction of human pharmacokinetics, ...

Roles at Kymera Therapeutics

  • VP, Preclinical Development

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.